These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 1343346

  • 1. Serum IgG subclass concentrations before and after administration of intravenous immunoglobulin in common variable immunodeficiency.
    Ozawa T, Motoyoshi F, Kato Y, Kondo N, Orii T.
    J Clin Lab Immunol; 1992; 38(1):29-39. PubMed ID: 1343346
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of immunoglobulin levels and infection rate in patients with common variable immunodeficiency after immunoglobulin replacement therapy.
    Salehzadeh M, Aghamohammadi A, Rezaei N.
    J Microbiol Immunol Infect; 2010 Feb; 43(1):11-7. PubMed ID: 20434118
    [Abstract] [Full Text] [Related]

  • 3. A case of IgG subclass deficiency with the initial presentation of transient hypogammaimmuno-globulinemia of infancy and a review of IgG subclass deficiencies.
    Nettagul R, Visitsunthorn N, Vichyanond P.
    J Med Assoc Thai; 2003 Jul; 86(7):686-92. PubMed ID: 12948264
    [Abstract] [Full Text] [Related]

  • 4. Immunoglobulin subclass concentration in preterm infants treated prophylactically with different intravenous immunoglobins.
    Amato M, Hüppi P, Imbach P, Llauto A, Bürgi W.
    Am J Perinatol; 1995 Sep; 12(5):306-9. PubMed ID: 8540928
    [Abstract] [Full Text] [Related]

  • 5. [Personal experience with replacement therapy with intravenous gamma globulin].
    Litzman J, Lokaj J, Stikarovská D, Mayer J, Thon V, Eibl MM.
    Vnitr Lek; 1995 Nov; 41(11):759-63. PubMed ID: 8553594
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of a new 10% intravenous immunoglobulin in patients receiving replacement therapy for primary immunodeficiency.
    Wasserman RL, Church JA, Peter HH, Sleasman JW, Melamed I, Stein MR, Bichler J, IgPro10 in PID Study group.
    Eur J Pharm Sci; 2009 Jun 28; 37(3-4):272-8. PubMed ID: 19491015
    [Abstract] [Full Text] [Related]

  • 7. Increases in serum immunoglobulins to age-related normal levels in children with IgA and/or IgG subclass deficiency.
    Kutukculer N, Karaca NE, Demircioglu O, Aksu G.
    Pediatr Allergy Immunol; 2007 Mar 28; 18(2):167-73. PubMed ID: 17338791
    [Abstract] [Full Text] [Related]

  • 8. Intravenous immunoglobulin replacement prevents severe and lower respiratory tract infections, but not upper respiratory tract and non-respiratory infections in common variable immune deficiency.
    Favre O, Leimgruber A, Nicole A, Spertini F.
    Allergy; 2005 Mar 28; 60(3):385-90. PubMed ID: 15679727
    [Abstract] [Full Text] [Related]

  • 9. Serum immunoglobulins and IgG subclass levels in adults with chronic sinusitis: evidence for decreased IgG3 levels.
    Armenaka M, Grizzanti J, Rosenstreich DL.
    Ann Allergy; 1994 Jun 28; 72(6):507-14. PubMed ID: 8203794
    [Abstract] [Full Text] [Related]

  • 10. Some but not all benefits of intravenous immunoglobulin therapy after marrow transplantation appear to correlate with IgG trough levels.
    Cottler-Fox M, Lynch M, Pickle LW, Cahill R, Spitzer TR, Deeg HJ.
    Bone Marrow Transplant; 1991 Jul 28; 8(1):27-33. PubMed ID: 1655138
    [Abstract] [Full Text] [Related]

  • 11. [Serum levels of IgG subclasses in critically ill premature infants treated with intravenous immunoglobulins].
    Puccio VF, Soliani M, Corea D, Puncuh F, Massone ML, Nahum L, Pisano F, Castellani R, Cornaglia-Ferraris P.
    Minerva Pediatr; 1991 Oct 28; 43(10):637-44. PubMed ID: 1758385
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of intravenous immunoglobulin treatment in children with common variable immunodeficiency.
    Baris S, Ercan H, Cagan HH, Ozen A, Karakoc-Aydiner E, Ozdemir C, Bahceciler NN.
    J Investig Allergol Clin Immunol; 2011 Oct 28; 21(7):514-21. PubMed ID: 22312934
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of Hizentra(®) in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapy.
    Jolles S, Bernatowska E, de Gracia J, Borte M, Cristea V, Peter HH, Belohradsky BH, Wahn V, Neufang-Hüber J, Zenker O, Grimbacher B.
    Clin Immunol; 2011 Oct 28; 141(1):90-102. PubMed ID: 21705277
    [Abstract] [Full Text] [Related]

  • 17. [IgG subclass deficiency in childhood. Changes in the antigen specific immune response and significance of low IgG4 level].
    Bartmann P, Fleischer S, Wagner H, Kleihauer E.
    Monatsschr Kinderheilkd; 1988 Jan 28; 136(1):31-7. PubMed ID: 2451127
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. IgG subclasses in symptomatic IgA deficiency.
    Tezcan I, Ersoy F, Sanal O.
    Turk J Pediatr; 1992 Jan 28; 34(1):1-4. PubMed ID: 1509524
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.